Inhibition of O-GlcNAc transferase renders prostate cancer cells dependent on CDK9 by Itkonen, HM, Poulose, N, Steele, RE, Martin, SES, Levine, ZG, Duveau, DY, Carelli, R, Singh, R, Urbanucci, A, Loda, M, Thomas, CJ, Mills, IG, Walker, S

‘Just because you don’t see your boss, doesn’t mean you don’t have a boss’: Covid- 19 and gig worker strikes across Latin America by Howson, K, Ustek-Spilda, F, Grohmann, R, Salem, N, Carelli, R, Abs, D, Salvagni, J, Graham, M, Balbornoz, MB, Chavez, H, Arriagada, A, Bonhomme, M

ELOVL5 is a critical and targetable fatty acid elongase in prostate cancer by Centenera, MM, Scott, JS, Machiels, J, Nassar, ZD, Miller, DC, Zininos, I, Dehairs, J, Burvenich, IJG, Zadra, G, Chetta, P, Bango, C, Evergren, E, Ryan, NK, Gillis, JL, Mah, CY, Tieu, T, Hanson, AR, Carelli, R, Bloch, K, Panagopoulos, V, Waelkens, E, Derua, R, Williams, ED, Evdokioou, A, Cifuentes-Rius, A, Voelcker, NH, Mills, IG, Tilley, WD, Scott, AM, Loda, M, Selth, LA, Swinnen, JV, Butler, LM